Oncolytics Biotech Inc., of Calgary, Alberta, said it completed patient enrollment in its U.S. Phase II trial testing intravenous administration of oncolytic virus Reolysin in combination with gemcitabine in patients with advanced or metastatic pancreatic cancer.
In the U.S. and Canada: 1-800-336-4474
Outside the U.S.: 1-215-386-0100
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Sign up for Perspectives FREE e-mail newsletter